79184 Federal Register / Vol. 85, No. 237 / Wednesday, December 9, 2020 / Notices 

Human Services (HHS), announces a 

webinar entitled, ‘‘CDC STI Treatment 

Guidelines Update’’. The purpose of the 

webinar is for CDC to receive comments 

from potential users on the proposed 

updated guidelines. This webinar is an 

opportunity for all interested parties to 

ask questions and provide feedback, but 

is specifically directed toward 

clinicians, such as medical doctors, 

nurse practitioners, and physician’s 

assistants. CDC will consider comments 

made during the webinar prior to 

finalizing the updated STI Treatment 

Guidelines for publication. 

DATES: The webinar will be held on 

December 18, 2020 from 2 p.m. to 4 p.m. 

EST. Registration instructions can be 

found on the website, https:// 

www.cdc.gov/std/treatment/default.htm. 

ADDRESSES: The webinar will be 

broadcast from the Centers for Disease 

Control and Prevention, 1600 Clifton 

Road NE, Atlanta, Georgia 30329. 

FOR FURTHER INFORMATION CONTACT: 

Quinn Haaga, Public Health Advisor, 

CDC, 1600 Clifton Road NE, MS–US 12– 

2, Atlanta, GA 30329, stdtxguidelines@

cdc.gov. 

SUPPLEMENTARY INFORMATION: The CDC’s 

STI Treatment Guidelines Webinar is a 

public presentation of proposed updates 

to the CDC’s 2015 STD Treatment 

Guidelines. The webinar will include 

discussions of proposed changes to 

CDC’s 2015 STD Treatment Guidelines 

focusing on (1) changes to testing, 

management, and/or treatment 

recommendations for Neisseria 

gonorrhoeae, Chlamydia trachomatis, 

Trichomonas vaginalis treatment; (2) 

role of metronidazole in pelvic 

inflammatory disease treatment; (3) 

alternative treatment options for 

bacterial vaginosis; (4) management of 

Mycoplasma genitalium; and (5) two 

step testing for serologic diagnosis of 

genital HSV2. Physicians and other 

health-care providers can use these 

guidelines to assist in the prevention 

and treatment of STIs. Comments and 

questions on the proposed changes may 

be made during the webinar only. 

Please refer to the posted agenda for 

updates about the webinar one week 

prior to the meeting. Information will be 

provided on the following website when 

it becomes available. https://

www.cdc.gov/std/treatment/default.htm. 

A recording of the webinar and 

accompanying transcripts will be 

available by January 17, 2021 on the 

website listed above. In addition, CDC’s 

responses to questions from the webinar 

will also be available February 15, 2021 

on this website. 

Participants must register by 

December 17, 2020. This is a webinaronly event and there will be no on-site 

participation at the CDC broadcast 

facility. 

Sandra Cashman, 

Executive Secretary, Centers for Disease 

Control and Prevention. 

[FR Doc. 2020–26974 Filed 12–8–20; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2020–0122] 

Advisory Committee on Immunization 

Practices (ACIP) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting and request 

for comment. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC), announces the 

following meeting of the Advisory 

Committee on Immunization Practices 

(ACIP). This meeting is open to the 

public. The meeting will be webcast live 

via the World Wide Web. 

DATES: The meeting will be held on 

December 11, 2020 from 12:00 p.m. to 

5:00 p.m. EST and December 13, 2020 

from 12:00 p.m. to 4:00 p.m. EST (times 

subject to change, see the ACIP website 

for any updates: http://www.cdc.gov/ 

vaccines/acip/index.html). 

Written comments must be received 

on or before December 14, 2020. 

ADDRESSES: For more information on 

ACIP please visit the ACIP website: 

http://www.cdc.gov/vaccines/acip/ 

index.html. 

You may submit comments, identified 

by Docket No. CDC–2020–0122 by any 

of the following methods: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Docket No. CDC–2020–0122, 

c/o Attn: December 11 and 13, 2020 

ACIP Meeting, Centers for Disease 

Control and Prevention, 1600 Clifton 

Road NE, MS H24–8, Atlanta, GA 

30329–4027. 

Instructions: All submissions received 

must include the Agency name and 

Docket Number. All relevant comments 

received in conformance with the 

https://www.regulations.gov suitability 

policy will be posted without change to 

https://www.regulations.gov, including 

any personal information provided. For 

access to the docket to read background 

documents or comments received, go to 

https://www.regulations.gov. 

FOR FURTHER INFORMATION CONTACT: 

Stephanie Thomas, ACIP Committee 

Management Specialist, Centers for 

Disease Control and Prevention, 

National Center for Immunization and 

Respiratory Diseases, 1600 Clifton Road 

NE, MS–H24–8, Atlanta, GA 30329– 

4027; Telephone: 404–639–8367; Email: 

ACIP@cdc.gov. 

SUPPLEMENTARY INFORMATION: In 

accordance with 41 CFR 102–3.150(b), 

less than 15 calendar days’ notice is 

being given for this meeting due to the 

exceptional circumstances of the 

COVID–19 pandemic and rapidly 

evolving COVID–19 vaccine 

development and regulatory processes. 

The Secretary of Health and Human 

Services has determined that COVID–19 

is a Public Health Emergency. A notice 

of this ACIP meeting has also been 

posted on CDC’s ACIP website at: http:// 

www.cdc.gov/vaccines/acip/index.html. 

In addition, CDC has sent notice of this 

ACIP meeting by email to those who 

subscribe to receive email updates about 

ACIP. 

Purpose: The committee is charged 

with advising the Director, CDC, on the 

use of immunizing agents. In addition, 

under 42 U.S.C. 1396s, the committee is 

mandated to establish and periodically 

review and, as appropriate, revise the 

list of vaccines for administration to 

vaccine-eligible children through the 

Vaccines for Children (VFC) program, 

along with schedules regarding dosing 

interval, dosage, and contraindications 

to administration of vaccines. Further, 

under provisions of the Affordable Care 

Act, section 2713 of the Public Health 

Service Act, immunization 

recommendations of the ACIP that have 

been approved by the Director of the 

Centers for Disease Control and 

Prevention and appear on CDC 

immunization schedules must be 

covered by applicable health plans. 

Matters To Be Considered: The agenda 

will include discussions on COVID–19 

vaccine. A recommendation vote(s) is 

scheduled. Agenda items are subject to 

change as priorities dictate. For more 

information on the meeting agenda visit 

https://www.cdc.gov/vaccines/acip/ 

meetings/meetings-info.html. 

Meeting Information: The meeting 

will be webcast live via the World Wide 

Web; for more information on ACIP 

please visit the ACIP website: http://

www.cdc.gov/vaccines/acip/index.html. 

Public Participation 

Interested persons or organizations 

are invited to participate by submitting 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 85, No. 237 / Wednesday, December 9, 2020 / Notices 79185 

written views, recommendations, and 

data. Please note that comments 

received, including attachments and 

other supporting materials are part of 

the public record and are subject to 

public disclosure. Do not include any 

information in your comment or 

supporting materials that you consider 

confidential or inappropriate for public 

disclosure. If you include your name, 

contact information, or other 

information that identifies you in the 

body of your comments, that 

information will be on public display. 

CDC will review all submissions and 

may choose to redact, or withhold, 

submissions containing private or 

proprietary information such as Social 

Security numbers, medical information, 

inappropriate language, or duplicate/ 

near duplicate examples of a mass-mail 

campaign. CDC will carefully consider 

all comments submitted into the docket. 

CDC does not accept comment by email. 

Written Public Comment: Written 

comments must be received on or before 

December 14, 2020. Oral Public 

Comment: This meeting will include 

time for members of the public to make 

an oral comment. Oral public comment 

will occur before any scheduled votes 

including all votes relevant to the 

ACIP’s Affordable Care Act and 

Vaccines for Children Program roles. 

Priority will be given to individuals 

who submit a request to make an oral 

public comment before the meeting 

according to the procedures below. 

Procedure for Oral Public Comment: 

All persons interested in making an oral 

public comment at the December 13, 

2020 ACIP meeting must submit a 

request at http://www.cdc.gov/vaccines/ 

acip/meetings/ no later than 11:59 p.m., 

EST, December 11, 2020 according to 

the instructions provided. 

If the number of persons requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

time, CDC will conduct a lottery to 

determine the speakers for the 

scheduled public comment session. 

CDC staff will notify individuals 

regarding their request to speak by email 

by 12:00 p.m., EST, December 12, 2020. 

To accommodate the significant interest 

in participation in the oral public 

comment session of ACIP meetings, 

each speaker will be limited to 3 

minutes, and each speaker may only 

speak once per meeting. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2020–27133 Filed 12–7–20; 4:15 pm] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

[OMB No. 0970–0234] 

Proposed Information Collection 

Activity; Social Services Block Grant 

(SSBG) Post-Expenditure Report, PreExpenditure Report, and Intended Use 

Plan 

AGENCY: Office of Community Services, 

Administration for Children and 

Families, HHS. 

ACTION: Request for Public Comment. 

SUMMARY: The Administration for 

Children and Families (ACF) is 

requesting a revision to the Social 

Services Block Grant (SSBG) PostExpenditure Report, Pre-Expenditure 

Report, and Intended Use Plan (OMB 

#0970–0234), previously titled, ‘‘Social 

Services Block Grant (SSBG) PostExpenditure Report’’). ACF is proposing 

to expand the information collection to 

include the collection of states’ 

Intended Use Plans and retitle the 

information collection to clarify the role 

of the Pre-Expenditure Report. 

DATES: Comments due within 60 days of 

publication. In compliance with the 

requirements of Section 3506(c)(2)(A) of 

the Paperwork Reduction Act of 1995, 

ACF is soliciting public comment on the 

specific aspects of the information 

collection described above. 

ADDRESSES: Copies of the proposed 

collection of information can be 

obtained and comments may be 

forwarded by emailing infocollection@

acf.hhs.gov. Alternatively, copies can 

also be obtained by writing to the 

Administration for Children and 

Families, Office of Planning, Research, 

and Evaluation (OPRE), 330 C Street 

SW, Washington, DC 20201, Attn: ACF 

Reports Clearance Officer. All requests, 

emailed or written, should be identified 

by the title of the information collection. 

SUPPLEMENTARY INFORMATION: 

Description: On an annual basis, 

states and territories are required to 

submit the following reports: (1) An 

Intended Use Plan that provides data 

and narrative descriptions related to the 

state’s SSBG program. The Intended Use 

Plan includes details about the delivery 

of SSBG services and the state agency 

administering the SSBG Program. ACF 

is proposing to expand the currently 

approved information collection to 

include collection of states’ Intended 

Use Plans. Grantees are required to 

submit their Intended Use Plans no less 

than 30 days prior to the start of the 

budget period covered by the report. (2) 

A Pre-Expenditure Report that 

demonstrates the state’s anticipated 

allocation of SSBG funding among the 

29 pre-defined SSBG service categories. 

Historically, states have submitted this 

report using the Post-Expenditure 

Report Form, and the associated burden 

is included in the currently approved 

information collection. Grantees are 

required to submit their PreExpenditure Report no less than 30 days 

prior to the start of the budget period 

covered by the report. (3) A PostExpenditure Report that details the 

state’s actual use of SSBG funding 

among each of the 29 service categories. 

Grantees are required to submit their 

Post-Expenditure Report within 6 

months of the end of the period covered 

by the report. 

Respondents: Agencies that 

administer the SSBG at the state or 

territory level, including the 50 states; 

District of Columbia; Puerto Rico; and 

the territories of American Samoa, 

Guam, the Virgin Islands, and the 

Commonwealth of Northern Mariana 

Islands. 

Annual Burden Estimates 

This request is specific to the 

Intended Use Plan. Currently approved 

materials and associated burden can be 

found at: https://www.reginfo.gov/ 

public/do/PRAViewICR?ref_nbr=

202011-0970-006. 

Instrument Annual number 

of respondents 

Annual number 

of responses 

per respondent 

Average burden 

hours per 

response 

Total/annual 

burden hours 

Intended Use Plan ................................................................................... 56 1 40 2,240 


jbell on DSKJLSW7X2PROD with NOTICES